EmbryoGen and BlastGen comprise the world‘s first media suite containing the recombinant human GM-CSF cytokine, for cleavage stage and blastocyst stage embryos.
These unique products aim to reduce stress caused to the embryo by creating a more physiological in vitro environment, improving the outcome of a successful implantation.